Yanan Bie

机构：Guangdong Pharmaceutical University · ORCID：0000-0001-9613-4609

发表论文 17 篇 · 总被引 137 次 · h-index 6

代表论文

• TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma (2021 · Frontiers in Cell and Developmental Biology · 被引 35)
• Multiparametric MRI Features Predict the SYP Gene Expression in Low-Grade Glioma Patients: A Machine Learning-Based Radiomics Analysis (2021 · Frontiers in Oncology · 被引 25)
• Genetically blocking HPD via CRISPR-Cas9 protects against lethal liver injury in a pig model of tyrosinemia type I (2021 · Molecular Therapy — Methods & Clinical Development · 被引 16)
• Lung adenocarcinoma organoids harboring EGFR 19Del and L643V double mutations respond to osimertinib and gefitinib (2021 · Medicine · 被引 13)
• Abnormalities of hair structure and skin histology derived from CRISPR/Cas9-based knockout of phospholipase C-delta 1 in mice (2018 · Journal of Translational Medicine · 被引 11)
• TZAP plays an inhibitory role in the self-renewal of porcine mesenchymal stromal cells and is implicated the regulation of premature senescence via the p53 pathway (2019 · Journal of Translational Medicine · 被引 9)